Mounjaro vs. Wegovy: Which Weekly Weight Loss Injection is Right for You?

Mounjaro vs. Wegovy: Which Weekly Weight Loss Injection is Right for You?

With the UK seeing a major shift in how we approach clinical weight management, two treatments have dominated the conversation: Mounjaro (tirzepatide) and Wegovy (semaglutide). Both are MHRA-approved, weekly injectable pens designed to help adults struggling with obesity or weight-related health conditions find long-term success.

But while they might seem similar on the surface, they work differently in the body, offer different average weight loss percentages, and feature distinct dosing schedules.

If you are looking to start your journey, here is an evidence-based breakdown of how they compare, how they work, and how to choose the right path for your health.

The Core Science: How Do They Work?

Both medications belong to a class of drugs known as receptor agonists, which mimic the natural hormones your gut releases after you eat to signal fullness to your brain. However, the way they target these receptors is where they differ.

1. Wegovy (Semaglutide)

Wegovy is a single-hormone agonist. It mimics GLP-1 (glucagon-like peptide-1), a hormone that slows down stomach emptying and targets the areas of the brain that regulate appetite and food cravings.

  • Read more or start a consultation: Buy Wegovy Online

2. Mounjaro (Tirzepatide)

Mounjaro is a dual-action “GIP/GLP-1” receptor agonist. It mimics both GLP-1 and another hormone called GIP (glucose-dependent insulinotropic polypeptide). The addition of GIP is thought to further enhance how the body breaks down fat and manages blood sugar, which often results in stronger appetite suppression.

Head-to-Head Comparison

When choosing between the two, clinical data, weight loss potential, and convenience are the key factors to consider.

FeatureWegovy (Semaglutide)Mounjaro (Tirzepatide)
Hormone TargetsGLP-1 onlyDual-Action GIP & GLP-1
FrequencyOnce weeklyOnce weekly
Average Weight LossUp to 15% – 20% body weightUp to 20.7% – 22.5% body weight
AdministrationSubcutaneous injectionSubcutaneous injection
Starting Dose0.25 mg2.5 mg

Clinical Trial Results: Which is More Effective?

While both options yield highly successful results when paired with a balanced, calorie-controlled diet and exercise, clinical trials show a slight edge for tirzepatide (Mounjaro).

LloydsPharmacy Online Doctor

  • Wegovy (STEP Trials): Over a 68-week clinical trial period, adults taking the maintenance dose of Wegovy (2.4mg) lost an average of 15% of their starting body weight.
  • Mounjaro (SURMOUNT Trials): In head-to-head research, patients taking the highest maintenance dose of Mounjaro (15mg) achieved an average weight reduction of up to 20.9% to 22.5% over 72 weeks.

Because everyone’s biology is different, some patients experience excellent results on Wegovy with fewer side effects, whereas others find that the dual-action approach of Mounjaro is better suited to quietening the persistent “food noise” in their daily lives.

LloydsPharmacy Online Doctor

Side Effects & Dose Escalation

Because both treatments slow down how quickly food leaves your stomach, the most common side effects are gastrointestinal. These are usually mild to moderate and improve as your body adjusts to the medication.

LloydsPharmacy Online Doctor

Common Side Effects:

  • Nausea or vomiting
  • Diarrhoea or constipation
  • Indigestion or acid reflux MedsDoctor
  • Fatigue

The Monthly Escalation Schedule

To minimise these symptoms, both treatments require a strict titration (step-up) schedule. You will start on the lowest dose for 4 weeks before discussing an increase with your prescriber.

  • Wegovy steps: 0.25mg ➔ 0.5mg ➔ 1.0mg ➔ 1.7mg ➔ 2.4mg LloydsPharmacy Online Doctor
  • Mounjaro steps: 2.5mg ➔ 5.0mg ➔ 7.5mg ➔ 10mg ➔ 12.5mg ➔ 15mg PrivateDoc

Who is Eligible in the UK?

To safely order either treatment from a UK-registered online pharmacy, you must meet the clinical criteria. Generally, weekly weight loss injections are prescribed to adults with:

  1. A BMI of 30 or above (clinically classified as obese). LloydsPharmacy Online Doctor
  2. A BMI of 27 or above alongside a weight-related health condition (such as high blood pressure, type 2 diabetes, high cholesterol, or joint issues). LloydsPharmacy Online Doctor

Before buying, you will complete a quick online consultation form reviewed by a registered clinical pharmacist to ensure the medication is safe for you.

LloydsPharmacy Online Doctor

How to Get Started Safely

If you are ready to take control of your weight management journey, the first step is to consult a qualified clinical professional.

LloydsPharmacy Online Doctor

At MedsProvider, we offer a fully regulated, confidential service. Our team reviews your medical history, checks your eligibility, and dispenses genuine MHRA-approved medications in discreet, temperature-controlled packaging straight to your door.

Pharmacy2U

Explore our complete weight management options:

  • Explore all options: Our Weight Loss Treatments & Programs
  • Start a free assessment: Begin Your Free Online Consultation

@zohaib@007_123@

See all author post

5 Comments

Leave a Reply

Your email address will not be published. Required fields are makes.